Opus Genetics, Inc.
IRD
$2.05
$0.063.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.84% | -34.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.84% | -34.05% | |||
| Cost of Revenue | 6.43% | -23.64% | |||
| Gross Profit | -6.05% | 10.69% | |||
| SG&A Expenses | -13.61% | -10.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.38% | -17.56% | |||
| Operating Income | 6.68% | 10.30% | |||
| Income Before Tax | -135.23% | 9.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -135.23% | 9.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -135.23% | 9.45% | |||
| EBIT | 6.68% | 10.30% | |||
| EBITDA | 6.68% | 10.33% | |||
| EPS Basic | -111.02% | 51.57% | |||
| Normalized Basic EPS | -110.93% | 51.56% | |||
| EPS Diluted | -111.02% | 51.57% | |||
| Normalized Diluted EPS | -110.93% | 51.56% | |||
| Average Basic Shares Outstanding | 11.46% | 87.03% | |||
| Average Diluted Shares Outstanding | 11.46% | 87.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||